Listen to our CEO, Young Kwon discuss Alchemab’s innovative platform and its novel approach to drug discovery on the pharmaphorum podcast. Learn More.

Cambridge, UK, September 5, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to disease, today announced that Young Kwon, PhD, Chief Executive Officer, will participate in a fireside chat at the Wells Fargo 2023 Healthcare Conference on 7 September 2023 at 4:30 p.m. ET. Please click here to […]

Our CEO Young Kwon was delighted to speak with Richard Staines of the Optimum  Perspectives Podcast on how Alchemab is revolutionizing antibody drug discovery with a novel alternative to the classic “choose a target” approach. Listen Here.

Alchemab CEO Young Kwon and Taylor Mixides from Drug Target Review discuss how Alchemab’s research has significant potential to transform the landscape of neurodegenerative disease research and improve the lives of those affected by these challenging conditions. Please click here to read more.